Neutrophil-to-Lymphocyte Ratio as a Marker of Acute Exacerbation and Disease Severity in Chronic Obstructive Pulmonary Disease
International Journal of Current Pharmaceutical Review and Research · 31.01.2026 · 18 (01)
DOI: 10.25258/ijcpr.18.1.269 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.01.2026. Verfasst von Aditya Bhardwaj und 2 weiteren Autor:innen.
Themen: COPD
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) is a systemic inflammatory disorder characterized by persistent airflow limitation and recurrent exacerbations. Identifying simple, cost-effective biomarkers that reflect disease severity and acute exacerbation is clinically valuable. The neutrophil-to-lymphocyte ratio (NLR), derived from routine complete blood counts, reflects systemic inflammation and immune balance.
Objectives
To evaluate the association of NLR with disease severity, pulmonary function, symptom burden, exercise capacity, and clinical features of acute exacerbation in COPD patients.
Methods
A cross-sectional study was conducted at Darbhanga Medical College and Hospital over one year. One hundred and five patients with clinically and spirometrically confirmed COPD were enrolled. Demographic, clinical, laboratory, spirometric, and radiological data were recorded. NLR was calculated from peripheral blood counts. Disease severity was assessed using GOLD staging, FEV1, mMRC dyspnea scale, six-minute walk distance (6MWD), BODE index, and presence of complications. Statistical analysis was performed using SPSS; p < 0.05 was considered significant.
Results
Mean NLR increased significantly with worsening mMRC grade, declining FEV1, higher GOLD stage, reduced 6MWD, higher BODE index, smoking status, biomass exposure, pulmonary hypertension, and features of acute exacerbation such as fever, wheeze, and crepitations. No significant association was observed with age, sex, BMI, hypertension, or place of residence.
Conclusion
NLR is a simple, inexpensive, and readily available biomarker that correlates well with COPD severity and acute exacerbation features. It may serve as an adjunct to conventional clinical and spirometric assessment, particularly in resource-limited settings.
Zitieren
APA
Bhardwaj, A., Jha, K. K., & Kumar, S. (2026). Neutrophil-to-Lymphocyte Ratio as a Marker of Acute Exacerbation and Disease Severity in Chronic Obstructive Pulmonary Disease. International Journal of Current Pharmaceutical Review and Research, 18(01). https://doi.org/10.25258/ijcpr.18.1.269
Vancouver
Bhardwaj A, Jha KK, Kumar S. Neutrophil-to-Lymphocyte Ratio as a Marker of Acute Exacerbation and Disease Severity in Chronic Obstructive Pulmonary Disease. International Journal of Current Pharmaceutical Review and Research. 2026;18(01). doi:10.25258/ijcpr.18.1.269
BibTeX
@article{Bhardwaj2026,
author = {Bhardwaj, Aditya and Jha, Krishna Kumar and Kumar, Sushil},
title = {Neutrophil-to-Lymphocyte Ratio as a Marker of Acute Exacerbation and Disease Severity in Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {01},
doi = {10.25258/ijcpr.18.1.269}
}
EUVIMED